- Home
- COUR vs SLNO Comparison
COUR vs SLNO Comparison
Compare COUR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COUR
- SLNO
- Stock Information
- Founded
- COUR 2012
- SLNO 1999
- Country
- COUR United States
- SLNO United States
- Employees
- COUR N/A
- SLNO N/A
- Industry
- COUR Computer Software: Prepackaged Software
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- COUR Technology
- SLNO Health Care
- Exchange
- COUR Nasdaq
- SLNO Nasdaq
- Market Cap
- COUR 1.5B
- SLNO 3.8B
- IPO Year
- COUR 2021
- SLNO 2014
- Fundamental
- Price
- COUR $8.07
- SLNO $82.27
- Analyst Decision
- COUR Hold
- SLNO Strong Buy
- Analyst Count
- COUR 13
- SLNO 9
- Target Price
- COUR $10.37
- SLNO $105.11
- AVG Volume (30 Days)
- COUR 1.5M
- SLNO 1.4M
- Earning Date
- COUR 07-24-2025
- SLNO 08-06-2025
- Dividend Yield
- COUR N/A
- SLNO N/A
- EPS Growth
- COUR N/A
- SLNO N/A
- EPS
- COUR N/A
- SLNO N/A
- Revenue
- COUR $704,874,000.00
- SLNO N/A
- Revenue This Year
- COUR $6.70
- SLNO N/A
- Revenue Next Year
- COUR $4.88
- SLNO N/A
- P/E Ratio
- COUR N/A
- SLNO N/A
- Revenue Growth
- COUR 7.25
- SLNO N/A
- 52 Week Low
- COUR $5.76
- SLNO $41.50
- 52 Week High
- COUR $11.74
- SLNO $90.32
- Technical
- Relative Strength Index (RSI)
- COUR 38.99
- SLNO 51.33
- Support Level
- COUR $8.34
- SLNO $79.70
- Resistance Level
- COUR $8.94
- SLNO $90.32
- Average True Range (ATR)
- COUR 0.28
- SLNO 3.66
- MACD
- COUR -0.04
- SLNO -0.41
- Stochastic Oscillator
- COUR 0.00
- SLNO 31.42
About COUR Coursera Inc.
Coursera Inc is an online learning platform that connects learners, educators, and institutions with the goal of providing educational content that is affordable, accessible, and relevant. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The company operates through three reporting segments: Consumer, Enterprise, and Degrees. The majority of revenue is generated from the Consumer segment. The consumer segment targets individual learners seeking to obtain hands-on learning, gain valuable job skills, receive professional-level certifications, and otherwise increase their knowledge to start or advance their careers.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.